Table 5.
Cytopathologic features of Bethesda III patients by histopathologic result (n = 59)
| Characteristics | All patients (n = 59), N(%) | Malignant (n = 38), N(%) | Benign (n = 21), N(%) | P |
|---|---|---|---|---|
| First FNAB | 0.108a | |||
| Cytologic atypia | 42 (71) | 29 (69) | 13 (31) | |
| Architectural atypia | 5 (8) | 1 (20) | 4 (80) | |
| Both cytologic and architectural atypia | 12 (20) | 8 (67) | 4 (33) | |
| Second FNAB | 0.211a | |||
| Cytologic atypia | 37 (63) | 24 (65) | 13 (35) | |
| Architectural atypia | 6 (10) | 2 (33) | 4 (67) | |
| Both cytologic and architectural atypia | 16 (27) | 12 (75) | 4 (25) |